Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan

Journal of Hepatology

Volumn 63, Issue 2, 2015, Pages 354-363

  Chen, Chi Ling ^a,b   Yang, Jyh Yuan ^c   Lin, Szu Fong ^c   Sun, Chien An ^d   Bai, Chyi Huey ^e   You, San Lin ^f   Chen, Chien Jen ^b,f   Kao, Jia Horng ^a,g   Chen, Pei Jer ^a,g   Chen, Ding Shinn ^a,f,g  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

HBV vaccination; Hepatitis B virus infection prevalence; Longitudinal follow up survey; Population based survey

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS B VACCINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BETEL NUT; BLOOD SAMPLING; COHORT ANALYSIS; ETHNIC GROUP; FEMALE; FOLLOW UP; FOOD INTAKE; GENOTYPE; HEALTH SURVEY; HEPATITIS B; HUMAN; INDIGENOUS PEOPLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; PRIORITY JOURNAL; RURAL AREA; SMOKING; TAIWAN; TAIWANESE; URBAN AREA; VACCINATION; VIRUS LOAD; ADOLESCENT; CLINICAL TRIAL; GENETICS; HEPATITIS B VIRUS; IMMUNOLOGY; MULTICENTER STUDY; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; MALE; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; TAIWAN; VACCINATION; VIRAL LOAD; YOUNG ADULT;

EID: 84942828021     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.03.013     Document Type: Article

References (31)

1. Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5-S16.
2. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-592.
3. Chen DS. Fighting against viral hepatitis: lessons from Taiwan. Hepatology 2011;54:381-392.
4. Chen DS, Hsu NHM, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis-B virus-infection in infants of hepatitis- B surface-antigen carrier mothers. JAMA 1987;257:2597-2603.
5. Chien YC, Jan CF, Kuo HS, Chen CJ. Nationwide hepatitis B vaccination program in Taiwan: effectiveness in the 20 years after it was launched. Epidemiol Rev 2006;28:126-135.
6. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999;179:367-370.
7. Chien YC, Jan CF, Chiang CJ, Kuo HS, You SL, Chen CJ. Incomplete hepatitis B immunization, maternal carrier status and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees. Hepatology 2014;60:125-132.
8. Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY, et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA 1996;276:906-908.
9. Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL. Base-line seroepidemiology of hepatitis-B virus-infection in children in Taipei, 1984 - A study just before mass hepatitis-B vaccination program in Taiwan. J Med Virol 1986;18: 301-307.
10. Hsu HM, Chen DS, Chuang CH, Lu JCF, Jwo DM, Lee CC, et al. Efficacy of a mass hepatitis-B vaccination program in Taiwan - Studies on 3464 infants of hepatitis-B surface-antigen carrier mothers. JAMA 1988;260:2231-2235.
11. Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA 2000;284:3040-3042.
12. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 2006;105:626-635.
13. Hwang LC, Bai CH, Chen CJ, Chien KL. Gender difference on the development of metabolic syndrome: a population-based study in Taiwan. Eur J Epidemiol 2007;22:899-906.
14. Yang T, Chu CH, Bai CH, You SL, Chou YC, Chou WY, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 2012;220:525-531.
15. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, et al. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. J Hepatol 2004;41:659-666.
16. Chen DS, Sung JL, Lai MY. A seroepidemiologic study of hepatitis B virus infection in Taiwan. J Formos Med Assoc 1978;77:908-918.
17. Sung JL. Hepatitis B virus infection and its sequelae in Taiwan. Gastroenterol Jpn 1984;19:363-366.
18. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology 2007;45:1187-1192.
19. Yu ML, Lee CM, Chuang WL, Lu SN, Dai CY, Huang JF, et al. HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. J Infect Dis 2010;202:86-92.
20. Chiou SS, Obata H, Takasaki T, Fukushima Y, Motoike Y, Okuda H, et al. Hepatitis viruses in southern Taiwan-mass survey of 2985 inhabitants. Gastroenterol Jpn 1984;19:344-350.
21. Beasley RP. Rocks along the road to the control of HBV and HCC. Ann Epidemiol 2009;19:231-234.
22. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
23. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-1293.
24. Ni YH, Chang MH, Wu JF, Hsu HY, Chen HL, Chen DS. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol 2012;57:730-735.
25. Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD, et al. Hepatitis B virus infection in adolescents in a rural township - 15 Years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006;24:759-765.
26. Huang ML, Liao WL, Ho MS. HBV serological markers of vaccinated children in remote areas of Taiwan: emphasis on factors contributing to vaccine failure. Vaccine 2007;25:6326-6333.
27. Wen WH, Chen HL, Ni YH, Hsu HY, Kao JH, Hu FC, et al. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology 2011;53: 429-436.
28. Chen CJ, Wang LY, Yu MW. Epidemiology of hepatitis B virus infection in the Asia-Pacific region. J Gastroenterol Hepatol 2000;15:E3-6.
29. Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011;154:319-328.
30. Wang LY, Hu CT, Ho TY, Lin HH. Geographic and ethnic variations of longterm efficacy and immunogenicity of hepatitis B vaccination in Hualien, a HBV hyperendemic area. Vaccine 2006;24:4427-4432.
31. Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012;30:2212-2219.